Chambal Biotech Ltd
NSE: CHAMBALBIOBSE: 549886Pharma Formulations
₹603.25
▲ 13.05 (+2.21%)
Key ratios
- Market cap
- ₹1,50,209 Cr
- Enterprise value
- ₹1,51,756 Cr
- 52-week range
- ₹570.60 – ₹723.45
- Day range
- ₹581.00 – ₹606.05
- P/E
- 24.79
- P/B
- 6.56
- EPS (TTM)
- ₹24.34
- Book value
- ₹92.00
- Dividend yield
- 1.97%
- ROE
- 26.53%
- ROCE
- 30.32%
- Debt / equity
- 0.26
- Interest cover
- 20.25x
- Current ratio
- 2.36
- Shares outstanding
- 249.00 Cr
- Face value
- ₹10.00
GroWiser rating
- Ownership5/5
- Valuation2/5
- Efficiency5/5
- Financials5/5
Scores (0–5) are calculated from published ratios using fixed thresholds. They describe the numbers and are not a recommendation to buy, sell or hold.
Strengths & limitations
Strengths
- Return on equity of 26.53% in the latest year.
- Sales have grown at 15.43% CAGR over 3 years.
- Interest is covered 20.25 times by operating profit.
- Promoter shareholding is 73.48%.
Limitations
- Nothing notable on our checks.
Generated automatically from the latest ratios using rule thresholds.
Growth (CAGR)
| 1Y | 3Y | 5Y | |
|---|---|---|---|
| Sales growth | +22.11% | +15.43% | +12.83% |
| Profit growth | +15.24% | +17.48% | +10.29% |
Compound annual growth based on annual results.
Ownership & margins
- Promoters
- 73.48%
- Pledged (promoter)
- 0.00%
- Operating margin
- 23.93%
- Net margin
- 16.41%
Peer comparison
| Company | Price | Market cap | P/E | ROE |
|---|---|---|---|---|
| Malabar Remedies | ₹3,154.80 | ₹1,91,181 Cr | 40.79 | 24.07% |
| Chambal Biotech | ₹603.25 | ₹1,50,209 Cr | 24.79 | 26.53% |
| Godavari Lifesciences | ₹883.50 | ₹28,007 Cr | 25.90 | 24.75% |
| Himgiri Pharma | ₹2,019.55 | ₹22,013 Cr | 28.36 | 15.75% |
About Chambal Biotech
Chambal Biotech Ltd is a fictitious company generated for demonstration. Its financial figures are sample data and do not describe any real business.
Frequently asked questions
What is the share price of Chambal Biotech?
The share price of Chambal Biotech was ₹603.25 as of 12 Nov 2026 (prices are delayed by 15 minutes).
What is the market cap of Chambal Biotech?
The market capitalisation of Chambal Biotech is ₹1,50,209 crore.
What is the P/E ratio of Chambal Biotech?
Chambal Biotech trades at a P/E of 24.79 based on trailing twelve-month EPS of ₹24.34.
Is Chambal Biotech debt free?
Chambal Biotech has a debt-to-equity ratio of 0.26.
What is the ROE of Chambal Biotech?
Chambal Biotech reported a return on equity of 26.53% and a return on capital employed of 30.32% in its latest financial year.
What is the promoter holding in Chambal Biotech?
Promoters hold 73.48% of Chambal Biotech; 0.00% of shares are pledged.